dc.contributor.author |
Sobirova D.R |
|
dc.contributor.author |
Azizova F.X., Ishandjanova S.X., Otajanova A.N., Utepova N.B. |
|
dc.date.accessioned |
2021-12-27T09:02:02Z |
|
dc.date.available |
2021-12-27T09:02:02Z |
|
dc.date.issued |
2021-11-11 |
|
dc.identifier.issn |
2776-1010 |
|
dc.identifier.uri |
http://repository.tma.uz/xmlui/handle/1/1123 |
|
dc.description.abstract |
The question of the need to prescribe antibiotic therapy to patients with exacerbation of chronic
obstructive pulmonary disease requires justification of the prescription of an antibiotic, taking into
account the likelihood of an etiological role of an infectious factor, the possibility of spontaneous
remissions, as well as the risk of negative consequences in case of unreasonable prescription
(development of microorganism resistance, unwanted side effects, unjustified costs) ... In addition, the
large arsenal of modern antibiotics poses the problem of choosing the optimal drug for the doctor. With
extreme caution, it is necessary to treat the choice of antibiotic therapy for patients with diabetes
mellitus with concomitant chronic obstructive pulmonary disease. |
en_US |
dc.language.iso |
en |
en_US |
dc.subject |
chronic obstructive pulmonary disease, diabetes mellitus, diabetic microangiopathy, microcirculation, lung tissue. |
en_US |
dc.title |
«Study of changes in pulmonary alveolar epithelium and aerogematic barrier in diabetes mellitus» |
en_US |
dc.type |
Article |
en_US |